Home » Market News » DirectorsTalk Highlights » Selena Gomez opens up on body-shaming comments
Immupharma Plc

Selena Gomez opens up on body-shaming comments

Selena Gomez has admitted to struggling after being “attacked” for gaining weight following her lupus diagnosis.

The chart-topping singer, 27, was diagnosed with lupus in 2015 and later underwent a kidney transplant due to complications from the autoimmune disease.

She said a combination of her medication and other “health issues” regularly affects her weight and admitted she “really noticed” when people commented on her body.

Few AIM-listed drug development companies have late-stage clinical assets in the pipeline, ImmuPharma plc (LON:IMM) is an exception. The Company’s lead compound, Lupuzor™, a potential treatment for Lupus, has completed Phase 3 trial of dosing patients across the US, Europe and Mauritius with top line results announced.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.